Definitive Contract HHSD200201562837C
Award Date
7/1/15
Potential Completion Date
6/30/16
Potential Value
$54M
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Pfizer Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $41,402,500.00 firm fixed price definitive contract awarded to Pfizer Inc. (Pfizer) by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for the provision of adult vaccines. The contract has a performance period ending on June 30, 2018, with no set-aside designation mentioned. As the prime contractor, Pfizer will be directly delivering the vaccines without the involvement of major subcontractors. The vaccines to be supplied include those for...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Definitive Contract to Pfizer Inc., a large pharmaceutical company, for the 2017 Vaccines for Children program. The contract has a potential value of $1,347,249,175.05 and a completion date of March 31, 2018. The contract does not have a set-aside designation. Under this award, Pfizer will provide a variety of pharmaceutical products and vaccines to support immunization programs...
This is a $21,494,073,684.68 Definitive, Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc. (Wyeth Division) for a pediatric vaccine program. The contract has an ultimate completion date of March 31, 2011 and was not set aside. This contract appears to be part of the CDC's Vaccines for Children (VFC) program, which provides vaccines at no cost to children who might not otherwise be vaccinated because of...
This $2,299,932.44 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the storage and rotation of Pfizer's COVID-19 vaccine. The contract has an ultimate completion date of July 31, 2022 and was awarded on August 1, 2017. The contract does not have a set-aside designation. Pfizer, a large global pharmaceutical corporation, is the prime contractor for this award. The contract is part of a larger Indefinite Delivery Vehicle (IDV) that...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the storage and rotation of Pfizer's COVID-19 vaccines. The contract has a ceiling value of $2,251,318.57 and a period of performance through July 31, 2027. It is a firm fixed-price contract, with no set-aside designation. Pfizer is the sole prime contractor, and there are no major subcontractors mentioned. This contract supports the CDC's national vaccination efforts and the...
This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...
This is a firm fixed-price delivery order awarded to Pfizer Inc. by the Defense Logistics Agency Troop Support Medical in the amount of $347,362.79. The contract has no set-aside designation. Pfizer, a large pharmaceutical company, will provide a variety of pharmaceutical products to U.S. government agencies, including COVID-19 vaccines, intravenous solutions, injections, vaccines, controlled substances, and other medical supplies. Pfizer also holds a Blanket Purchase Agreement against the...
This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Pfizer Inc.'s Wyeth division. The contract, valued at $15,297,409,927.00, is for the Vaccines for Children (VFC) Pediatric Vaccine Contract and has a period of performance ending on March 31, 2010. The contract is a Definitive Contract with a Firm Fixed Price pricing type and does not have a set-aside designation. The contract is for the delivery of pediatric vaccines...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Pfizer Inc., doing business as Pfizer, a $103,298.40 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract. Pfizer will provide COVID-19 (COMIRNATY) vaccines to the CDC from September 22, 2023 through October 31, 2023. The delivery order supports the CDC's ongoing efforts to purchase and distribute COVID-19 vaccines as part of its pandemic response...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, with a ceiling value of $1,135.77, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine over a period of 6 months to 4 years, with an ultimate completion date...